Baharudin et al. found that recurrent CRC patients exhibited higher methylation levels and the recurrence of CRC compared to non‐recurrent CRC patients, which might associate with the abnormal methylation of CCNEI, CCNDBP1, CHL1, DDX43, and PON3. The gene discussed is CCNDBP1; the disease is colorectal carcinoma.